AEAnna V. El'SKaya

Anna V. El'SKaya

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Anna V. El'SKaya has a total of 286 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A few notes on science in Ukraine

    by Anna V. El'SKaya


  • Open Access

    A Novel Conductometric Urea Biosensor with Improved Analytical Characteristic Based on Recombinant Urease Adsorbed on Nanoparticle of Silicalite

    by T. P. Velychko, О. О. Soldatkin, V. G. Melnyk, S. V. Marchenko, S. K. Kirdeciler, B. Akata, A. P. Soldatkin, A. V. El’skaya, S. V. Dzyadevych

    Development of a conductometric biosensor for the urea detection has been reported. It was created using a non-typical method of the recombinant urease immobilization via adsorption on nanoporous particles of silicalite. It should be noted that this biosensor has a number of advantages, such as simple and fast performance, the absence of toxic compounds during biosensor preparation, and high reproducibility (RSD = 5.1 %). The linear range of urea determination by using the biosensor was 0.05–15 mM, and a lower limit of urea detection was 20 μM. The bioselective element was found to be stable for 19 days. The characteristics of recombinant urease-based biomembranes, such as dependence of responses on the protein and ion concentrations, were investigated. It is shown that the developed biosensor can be successfully used for the urea analysis during renal dialysis.

  • A non‐catalytic N‐terminal domain negatively influences the nucleotide exchange activity of translation elongation factor 1Bα

    by Tetiana V. Trosiuk, Vyacheslav F. Shalak, Roman H. Szczepanowski, Boris S. Negrutskii, Anna V. El'SKaya

    Eukaryotic translation elongation factor 1Bα (eEF1Bα) is a functional homolog of the bacterial factor EF‐Ts, and is a component of the macromolecular eEF1B complex. eEF1Bα functions as a catalyst of guanine nucleotide exchange on translation elongation factor 1A (eEF1A). The C‐terminal domain of eEF1Bα is necessary and sufficient for its catalytic activity, whereas the N‐terminal domain interacts with eukaryotic translation elongation factor 1Bγ (eEF1Bγ) to form a tight complex. However, eEF1Bγ has been shown to enhance the catalytic activity of eEF1Bα attributed to the C‐terminal domain of eEF1Bα. This suggests that the N‐terminal domain of eEF1Bα may in some way influence the guanine nucleotide exchange process. We have shown that full‐length recombinant eEF1Bα and its truncated forms are non‐globular proteins with elongated shapes. Truncation of the N‐terminal domain of eEF1Bα, which is dispensable for catalytic activity, resulted in acceleration of the rate of guanine nucleotide exchange on eEF1A compared to full‐length eEF1Bα. A similar effect on the catalytic activity of eEF1Bα was observed after its interaction with eEF1Bγ. We suggest that the non‐catalytic N‐terminal domain of eEF1Bα may interfere with eEF1A binding to the C‐terminal catalytic domain, resulting in a decrease in the overall rate of the guanine nucleotide exchange reaction. Formation of a tight complex between the eEF1Bγ and eEF1Bα N‐terminal domains abolishes this inhibitory effect.


  • Translation elongation factor eEF1A1 is a novel partner of a multifunctional protein Sgt1

    by Oleksandra Novosylna, Ewelina Jurewicz, Nikolay Pydiura, Agnieszka Goral, Anna Filipek, Boris Negrutskii, Anna El'SKaya


  • Truncation of the A,A∗,A′ helices segment impairs the actin bundling activity of mammalian eEF1A1

    by Dmytro O. Vlasenko, Oleksandra V. Novosylna, Boris S. Negrutskii, Anna V. El'Skaya

    Translation elongation factor eEF1A is a G-protein which has a crucial role in the ribosomal polypeptide elongation and possesses a number of non-translational functions. Here, we show that the A,A∗,A′ helices segment of mammalian eEF1A is dispensable for the eEF1A*eEF1Bα complex formation. The A,A∗,A′ helices region did not interact with actin; however, its removal eliminates the actin bundling activity of eEF1A, probably due to the destruction of a dimeric structure of eEF1A. The translation function of monomers and the actin-bundling function of dimers of mammalian eEF1A is suggested


  • Application of potentiometric biosensor based on recombinant urease for urea determination in blood serum and hemodialyzate

    by S.V. Marchenko, I.S. Kucherenko, A.N. Hereshko, I.V. Panasiuk, O.O. Soldatkin, A.V. El'SKaya, A.P. Soldatkin


  • Open Access

    Independent overexpression of the subunits of translation elongation factor complex eEF1H in human lung cancer

    by Maryna Veremieva, Liudmyla Kapustian, Antonina Khoruzhenko, Valery Zakharychev, Boris Negrutskii, Anna El’sKaya

    The constituents of stable multiprotein complexes are known to dissociate from the complex to play independent regulatory roles. The components of translation elongation complex eEF1H (eEF1A, eEF1Bα, eEF1Bβ, eEF1Bγ) were found overexpressed in different cancers. To gain the knowledge about novel cancer-related translational mechanisms we intended to reveal whether eEF1H exists as a single unit or independent subunits in different human cancers. The changes in the expression level of every subunit of eEF1H in the human non-small-cell lung cancer tissues were examined. The localization of eEF1H subunits was assessed by immunohistochemistry methods, subcellular fractionation and confocal microscopy. The possibility of the interaction between the subunits was estimated by co-immunoprecipitation. The level of eEF1Bβ expression was increased more than two-fold in 36%, eEF1Bγ in 28%, eEF1A in 20% and eEF1Bα in 8% of tumor specimens. The cancer-induced alterations in the subunits level were found to be uncoordinated, therefore the increase in the level of at least one subunit of eEF1H was observed in 52% of samples. Nuclear localization of eEF1Bβ in the cancer rather than distal normal looking tissues was found. In cancer tissue, eEF1A and eEF1Bα were not found in nuclei while all four subunits of eEF1H demonstrated both cytoplasmic and nuclear appearance in the lung carcinoma cell line A549. Unexpectedly, in the A549 nuclear fraction eEF1A lost the ability to interact with the eEF1B complex. The results suggest independent functioning of some fraction of the eEF1H subunits in human tumors. The absence of eEF1A and eEF1B interplay in nuclei of A549 cells is a first evidence for non-translational role of nuclear-localized subunits of eEF1B. We conclude the appearance of the individual eEF1B subunits in tumors is a more general phenomenon than appreciated before and thus is a novel signal of cancer-related changes in translation apparatus.


  • Open Access

    Mammalian translation elongation factor eEF1A2: X-ray structure and new features of GDP/GTP exchange mechanism in higher eukaryotes

    by Thibaut Crepin, Vyacheslav F. Shalak, Anna D. Yaremchuk, Dmytro O. Vlasenko, Andrew McCarthy, Boris S. Negrutskii, Michail A. Tukalo, Anna V. El'SKaya

    Eukaryotic elongation factor eEF1A transits between the GTP- and GDP-bound conformations during the ribosomal polypeptide chain elongation. eEF1A*GTP establishes a complex with the aminoacyl-tRNA in the A site of the 80S ribosome. Correct codon–anticodon recognition triggers GTP hydrolysis, with subsequent dissociation of eEF1A*GDP from the ribosome. The structures of both the ‘GTP’- and ‘GDP’-bound conformations of eEF1A are unknown. Thus, the eEF1A-related ribosomal mechanisms were anticipated only by analogy with the bacterial homolog EF-Tu. Here, we report the first crystal structure of the mammalian eEF1A2*GDP complex which indicates major differences in the organization of the nucleotide-binding domain and intramolecular movements of eEF1A compared to EF-Tu. Our results explain the nucleotide exchange mechanism in the mammalian eEF1A and suggest that the first step of eEF1A*GDP dissociation from the 80S ribosome is the rotation of the nucleotide-binding domain observed after GTP hydrolysis.


  • Open Access

    mRNAs coding for A1 and A2 isoforms of translation factor eEF1A demonstrate different half-lives while A1 and A2 proteins are similarly stable in MCF7 cells

    by A. A. Vislovukh, N. L. Gralievska, M. G. Naumovets, B. S. Negrutskii, A. V. El'SKaya

    Eukaryotic translation elongation factor 1A (eEF1A) exists as two 98 % homologous isoforms eEF1A1 and eEF1A2 that are tissue/development specific and differentially linked to apoptosis/cancerogenesis. A2 is overexpressed in a number of tumors while unusual expression of A1 is observed in injured muscles. To approach a possible mechanism underlying induced changes in the relative amounts of the isoforms we examined the intrinsic stability of the proteins and their mRNAs in human cancer cells. Aim. To estimate half-life of the isoforms of eEF1A at mRNA and protein level in human cancer cells. Methods. To measure mRNA stability the transcriptional block technique was applied, with subsequent analysis of the mRNA level by qPCR. To determine the protein decay rate the translation was blocked by cycloheximide and changes in the protein level were detected by Western blot. Results. Calculation of the protein stability revealed half-life of 72 for eEF1A1 and 95 hours for eEF1A2. Half-life of EEF1A1 and EEF1A2 mRNAs were 3 and 60 hours respectively. Conclusions. Despite similar protein stability, the isoforms of eEF1A dramatically differ in the half-lives of their mRNAs, suggesting that the mRNA decay mechanism is one of the main regulators of eEF1A1/A2 amount in MCF7 cancer cells


  • Open Access

    Proto-oncogenic isoform A2 of eukaryotic translation elongation factor eEF1 is a target of miR-663 and miR-744

    by A Vislovukh, G Kratassiouk, E Porto, N Gralievska, C Beldiman, G Pinna, A El'Skaya, A Harel-Bellan, B Negrutskii, I Groisman

    Eukaryotic translation elongation factor 1A2 (eEF1A2) is a known proto-oncogene. We proposed that stimulation of the eEF1A2 expression in cancer tissues is caused by the loss of miRNA-mediated control. Impact of miRNAs on eEF1A2 at the mRNA and protein levels was examined by qPCR and western blot, respectively. Dual-luciferase assay was applied to examine the influence of miRNAs on 3′-UTR of EEF1A2. To detect miRNA-binding sites, mutations into the 3′-UTR of EEF1A2 mRNA were introduced by the overlap extension PCR. miR-663 and miR-744 inhibited the expression of luciferase gene attached to the 3′-UTR of EEF1A2 up to 20% and 50%, respectively. In MCF7 cells, overexpression of miR-663 and miR-744 reduced the EEF1A2 mRNA level by 30% and 50%. Analogous effects were also observed at the eEF1A2 protein level. In resveratrol-treated MCF7 cells the upregulation of mir-663 and mir-744 was accompanied by downregulation of EEF1A2 mRNA. Both miRNAs were able to inhibit the proliferation of MCF7 cells. miR-663 and miR-744 mediate inhibition of the proto-oncogene eEF1A2 expression that results in retardation of the MCF7 cancer cells proliferation. Antitumour effect of resveratrol may include stimulation of the miR-663 and miR-744 expression.